Joined NIF Ventures (now known as Daiwa Corporate Investment, "DCI") in 2005. Mr. Kodama was responsible for domestic and overseas investments in biopharmaceutical companies at NIF. In 2014, the life science team was spun off from DCI and established a new VC firm called DCI Partners. DCI Partners is a leading Japanese venture capital firm dedicated to life sciences and now has over JPY 26 billion in AUM across 2 funds. He is an initial member as well as an investment committee member of DCI Partners. He has 20 years' VC investment career and is currently serving on the board of directors for multiple portfolio companies in Japan and Taiwan including Orthorebirth, LUCA Science, REGiMMUNE and JUNTEN BIO.

Back